Wall Street Experts
ver. ZuMIgo(08/25)
IGM Biosciences, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 3
EBIT TTM (mln): -235
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
Rok finansowy |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
3 |
Przychód Δ r/r |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
inf% |
99.3% |
25.8% |
Marża brutto |
0.0% |
0.0% |
-inf% |
-inf% |
-inf% |
-891.8% |
-288.6% |
100.0% |
EBIT (mln) |
-11 |
-23 |
-44 |
-83 |
-165 |
-228 |
-263 |
-209 |
EBIT Δ r/r |
0.0% |
104.5% |
95.2% |
87.2% |
98.5% |
37.9% |
15.6% |
-20.8% |
EBIT (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-21324.2% |
-12369.1% |
-7785.7% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
-7 |
0 |
0 |
EBITDA (mln) |
-11 |
-23 |
-44 |
-83 |
-165 |
-228 |
-255 |
-209 |
EBITDA(%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-21324.2% |
-11980.5% |
-7785.7% |
Podatek (mln) |
0 |
0 |
-1 |
-1 |
-4 |
-7 |
1 |
0 |
Zysk Netto (mln) |
-11 |
-23 |
-43 |
-80 |
-161 |
-214 |
-246 |
-196 |
Zysk netto Δ r/r |
0.0% |
105.5% |
87.3% |
88.9% |
100.0% |
33.3% |
15.0% |
-20.5% |
Zysk netto (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-20041.9% |
-11568.8% |
-7308.5% |
EPS |
-1.49 |
-3.07 |
-4.73 |
-2.61 |
-4.8 |
-5.16 |
-4.71 |
-3.24 |
EPS (rozwodnione) |
-1.49 |
-3.07 |
-4.73 |
-2.61 |
-4.8 |
-5.16 |
-4.71 |
-3.24 |
Ilośc akcji (mln) |
7 |
7 |
9 |
31 |
33 |
42 |
52 |
61 |
Ważona ilośc akcji (mln) |
7 |
7 |
9 |
31 |
33 |
42 |
52 |
61 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |